Related Experiment Video
Updated: Jun 1, 2026

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Conduction Disorders: The Achilles' Heel of TAVR?
Antonin Fournier1, Pierre Robert2, Jean-Christophe Macia1
1Department of Cardiology, CHU Montpellier, Arnaud de Villeneuve Hospital, University of Montpellier, Avenue du doyen Giraud, 34295 Montpellier, France.
Journal of Clinical Medicine
|February 13, 2026
Summary
High degree conductive disorders after TAVR, a complication requiring permanent pacemaker implantation, are reviewed. This analysis focuses on predicting and managing these events to optimize patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Electrophysiology
Background:
- High-degree conductive disorders (CD) requiring permanent pacemaker implantation (PPI) are significant complications following transcatheter aortic valve replacement (TAVR).
- Current management strategies for post-TAVR CD remain controversial, highlighting a need for clearer guidelines.
Purpose of the Study:
- To review the mechanisms and risk factors associated with CD after TAVR.
- To evaluate the role of electrocardiogram (ECG) and multi-slice computed tomography (MSCT) in assessing anatomical parameters for CD risk.
- To summarize strategies for anticipating, detecting, and managing high-degree CD and optimizing PPI indications post-TAVR.
Main Methods:
- Narrative review of existing literature.
- Literature search using keywords: conductive disorders, TAVR, and pacemaker implantation.
- Focus on ECG evaluation, anatomical parameters from MSCT, and procedural aspects.
Main Results:
- Conductive disorders requiring permanent pacemaker implantation are a primary complication of TAVR.
- A comprehensive evaluation integrating ECG, MSCT-derived anatomical data, and procedural factors is crucial for risk assessment.
- Optimizing PPI indications and exploring novel monitoring and pacing techniques are essential for improved patient care.
Conclusions:
- There is a need for improved strategies to anticipate and detect high-degree CD after TAVR to reduce incidence.
- Clearer recommendations for PPI indications are required to optimize outcomes for patients undergoing TAVR.
- Future perspectives include ambulatory monitoring, machine learning, and advanced pacing techniques for managing post-TAVR CD.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

